Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9

Jame Abraham; André Robidoux; Antoinette R. Tan; Steven Limentani; Keren Sturtz; Ibrahim Shalaby; Hope Alcorn; Marc E. Buyse; Norman Wolmark; Samuel A. Jacobs

doi:10.1007/s10549-015-3466-4

Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3466-4 ◽

2015 ◽

Vol 152 (2) ◽

pp. 399-405 ◽

Cited By ~ 9

Author(s):

Jame Abraham ◽

André Robidoux ◽

Antoinette R. Tan ◽

Steven Limentani ◽

Keren Sturtz ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Randomized Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Weekly Paclitaxel

Download Full-text

Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel (WP) or eribulin (E) followed by doxorubicin and cyclophosphamide (AC) in women with locally advanced HER2-negative breast cancer (LABC): NSABP FB-9.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.1058 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 1058-1058 ◽

Cited By ~ 2

Author(s):

Jame Abraham ◽

Andre Robidoux ◽

Antoinette R. Tan ◽

Marc E. Buyse ◽

Norman Wolmark ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Randomized Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Weekly Paclitaxel

Download Full-text

Abstract OT1-1-12: NSABP FB-7 Trial: A Phase II Randomized Clinical Trial Evaluating Neoadjuvant Therapy Regimens with Weekly Paclitaxel and Neratinib or Trastuzumab or Neratinib and Trastuzumab Followed by Doxorubicin and Cyclophosphamide with Postoperative Trastuzumab in Women with Locally Advanced HER2-Positive Breast Cancer

10.1158/0008-5472.sabcs12-ot1-1-12 ◽

2012 ◽

Author(s):

J Lu ◽

SA Jacobs ◽

ME Buyse ◽

S Paik ◽

N Wolmark

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Neoadjuvant Therapy ◽

Randomized Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Weekly Paclitaxel ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

Oncotarget ◽

10.18632/oncotarget.17954 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79305-79314 ◽

Cited By ~ 12

Author(s):

Liheng Zhou ◽

Shuguang Xu ◽

Wenjin Yin ◽

Yanpin Lin ◽

Yueyao Du ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

Download Full-text

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination with Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2021.05.009 ◽

2021 ◽

Author(s):

LK Symonds ◽

I Jenkins ◽

HM Linden ◽

B Kurland ◽

JR Gralow ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Inflammatory Breast Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Weekly Paclitaxel ◽

Oral Cyclophosphamide ◽

Sunitinib Malate ◽

Safety And Efficacy

Download Full-text

Abstract P1-16-03: Phase II randomized clinical trial (RCT) of metformin (MET) vs placebo (PLAC) in combination with chemotherapy (CXT) in refractory locally advanced (LABC) or metastatic breast cancer (MBC)

10.1158/1538-7445.sabcs18-p1-16-03 ◽

2019 ◽

Author(s):

PJ Goodwin ◽

M Ennis ◽

DW Cescon ◽

C Elser ◽

R Haq ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast Cancer ◽

Randomized Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Metastatic Breast

Download Full-text

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Breast Cancer Research and Treatment ◽

10.1007/s10549-020-05940-8 ◽

2020 ◽

Author(s):

Yi-Zhou Jiang ◽

Li-Ping Ge ◽

Xi Jin ◽

Lei Fan ◽

Min He ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Locally Advanced ◽

Phase Ii Clinical Trial ◽

Randomized Phase Ii ◽

Biomarker Analysis

Download Full-text

Gemcitabine/Epirubicin/Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group

Clinical Breast Cancer ◽

10.3816/cbc.2008.n.029 ◽

2008 ◽

Vol 8 (3) ◽

pp. 257-263 ◽

Cited By ~ 6

Author(s):

John T. Hamm ◽

John W. Wilson ◽

Priya Rastogi ◽

Barry C. Lembersky ◽

George C. Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Research Group ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast

Download Full-text

OT2-01-03: Eribulin in Women with Locally Advanced Breast Cancer Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy: A Sarah Cannon Research Institute Phase II Trial.

10.1158/0008-5472.sabcs11-ot2-01-03 ◽

2011 ◽

Author(s):

DA Yardley ◽

NW Peacock ◽

JD Hainsworth ◽

III HA Burris

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Pathologic Complete Response ◽

Complete Response ◽

Advanced Breast

Download Full-text

Abstract CT302: A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease

10.1158/1538-7445.am2014-ct302 ◽

2014 ◽

Author(s):

Stacy Cowherd ◽

Susan Melin ◽

Steven Akman ◽

John Cole ◽

Julia Lawrence

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Cancer Patients ◽

Phase Ii ◽

Triple Negative ◽

Recurrent Breast Cancer ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel ◽

Breast Cancer Patients ◽

Recurrent Breast

Download Full-text

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer

Cancer Biology & Therapy ◽

10.1080/15384047.2015.1026481 ◽

2015 ◽

Vol 16 (5) ◽

pp. 678-683 ◽

Cited By ~ 15

Author(s):

S Cowherd ◽

L D Miller ◽

S A Melin ◽

S Akman ◽

S Isom ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Clinical Trial ◽

Weekly Paclitaxel

Download Full-text